#106 James Simpkins, PhD: Delivering Genes to the Brain

Published: Nov. 13, 2023, 10 a.m.

b'

Healthcare is changing every day, and AmritaGen is pioneering the discovery of a new gene therapy for treating neurodegenerative diseases. Dr. James Simpkins is the CEO of AmritaGen, a company seeking to rebuild brain circuits and stimulate neurological activity in people with mild cognitive impairment. This therapy method can be utilized for delivering drug treatments for Alzheimer\\u2019s disease (AD), sporadic AD (sAD), Parkinson\\u2019s disease, stroke, and Traumatic Brain Injury.\\xa0

To learn more about AmritaGen, vist them at\\xa0https://amritagen.com

To learn more about Innovate Fort Worth, visit\\xa0https://innovatefortworthpodcast.com

'